PolyPeptide Group AG Stock OTC Markets
Stocks
PLYG.F
CH1110760852
Pharmaceuticals
OTC Markets Traded| Market Cap | 1.67B 1.9B 1.53B 1.44B 2.69B 179B 2.75B 18.45B 7.14B 88.53B 7.13B 6.98B 307B | P/E 2026 * |
70.5x | P/E 2027 * | 38.1x |
|---|---|---|---|---|---|
| Enterprise Value | 1.77B 2.01B 1.63B 1.52B 2.86B 190B 2.92B 19.57B 7.57B 93.93B 7.57B 7.4B 326B | EV / Sales 2026 * |
3.59x | EV / Sales 2027 * | 3.16x |
| Free-Float |
39.12% | Yield 2026 * |
-
| Yield 2027 * | 0.06% |
Last Transcript: PolyPeptide Group AG
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 2023-04-11 | |
Marc Augustin
DFI | Director of Finance/CFO | 54 | 2024-01-01 |
| Chief Tech/Sci/R&D Officer | 54 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jane Salik
BRD | Director/Board Member | 73 | 2005-12-31 |
Peter Wilden
CHM | Chairman | 69 | 2021-03-31 |
Erik Schropp
BRD | Director/Board Member | 62 | 2020-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.9B | |
| +7.13% | +9.97% | +51.94% | +166.83% | 1,077B | |
| +3.99% | +11.50% | +67.53% | +55.63% | 613B | |
| +4.20% | +17.03% | +35.63% | +87.74% | 448B | |
| +0.99% | +4.85% | +27.93% | +22.82% | 332B | |
| +1.82% | +8.19% | +41.15% | +26.80% | 293B | |
| +0.22% | +6.75% | +31.51% | +42.02% | 286B | |
| +0.73% | +8.53% | -26.22% | -40.85% | 215B | |
| +1.56% | +6.14% | +28.38% | +59.45% | 193B | |
| +3.26% | +3.33% | +18.83% | +67.03% | 159B | |
| Average | +1.86% | +8.00% | +30.74% | +54.16% | 401.79B | |
| Weighted average by Cap. | +2.26% | +8.93% | +40.51% | +81.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 492M 561M 453M 424M 796M 52.92B 812M 5.45B 2.11B 26.15B 2.11B 2.06B 90.69B | 568M 648M 523M 490M 919M 61.1B 938M 6.29B 2.43B 30.19B 2.43B 2.38B 105B |
| Net income | 23.54M 26.85M 21.7M 20.31M 38.09M 2.53B 38.88M 261M 101M 1.25B 101M 98.6M 4.34B | 43.85M 50.01M 40.42M 37.84M 70.95M 4.72B 72.43M 486M 188M 2.33B 188M 184M 8.08B |
| Net Debt | 101M 116M 93.52M 87.56M 164M 10.92B 168M 1.12B 435M 5.39B 435M 425M 18.71B | 130M 148M 120M 112M 210M 13.95B 214M 1.44B 556M 6.9B 555M 543M 23.91B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
